Navigation Links
Ireland: Heart Disease Deaths Drop By Half.

Research in the Journal of Epidemiology and Community Health reports that deaths from coronary artery heart disease in Ireland has reduced by almost half since the Mid 1980s. // This is attributed mainly to lifestyle changes, and reduction in smoking, the study reveals.

Deaths from coronary artery disease in Ireland, dropped by almost 47%, between 1985 and 2000, among ages 25 to 84, and this meant nearly 3800 fewer deaths when compared to figures in 1985. This drop was because of better and timely health treatment and cessation of smoking that contributed to nearly 48% of the reduction in the rates.

The smoking cessation programmes received an impetus, after ban on workplace smoking in Ireland, that was enforced in 2004. Smoking rates have certainly dropped in Ireland, as compared to United Kingdom or any other developed country.

But there has been an increase in rates of obesity, diabetes, and lifestyle is marked with little or nil physical activity, that threatens to swing these healthy signs by around 13% or 500 deaths. The authors have advised that if lifestyle changes are not seriously made, the tables will certainly be turned on the health advantages made in Ireland.


'"/>




Page: 1

Related medicine news :

1. Ireland: Two diet drinks off the shelf due to benzene
2. One in Three Heart Attack Patients Have No Chest Pains
3. Epileptic Seizures Can Be Due to Heart Problem
4. Bypass Heart Surgery Performed Without General Anesthesia
5. New CPR Guidelines issued by Heart Association
6. White Cells Count Can Predict Heart Attack Death Risk
7. Vitamins-The answer to Heart Disease?
8. Fight Heart disease and Pain with Meditation
9. Heart disease in the newborn is related to maternal malnutrition
10. New drug to treat Heart Attack and damaged tissue
11. Heart disease threat starts early in life for Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ireland Heart Disease Deaths Drop Half

(Date:12/2/2008)...Provides Online Resource and Fire Safety Tips for ... Boston, MA (PRWEB) December 2, 2008 --...ete , actress, philanthropist and mother of four, ...a few moments before the holiday rush to review fi...Smart.com. , , , , ,Home fires top the list of Am...
(Date:12/1/2008)...Patient satisfaction scores at,outpatient health ... report,from Press Ganey Associates, Inc. The 20...on American Health Care cites increased competitio... patient services. The report,includes responses... than,1,200 outpatient care facilities nationwide...
(Date:12/1/2008)...e availability of a portable eight-slice computed ...ignificantly increase the number of stroke victims...Results of the study, conducted at North Shore Med... will be presented today at the annual meeting of ... , "The hospital,s acquisition of a portable CT ...
(Date:12/1/2008)...nection between second-hand smoke and coronary hea...s passed to reduce such passive smoking, exposures... January 2009 issue of the American Journal of Pr...y of California, San Francisco, Partners Healthcar...d the CHD Policy Model to better predict future tr...
Breaking Medicine News(10 mins):Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2
...e city's health services panel Friday approved a p...fixed fine for anyone who breaches tough new anti-...rafted in to back up the teams of tobacco control ...ponsibility of enforcing the no-smoking policy. S...
... researchers have found evidence that tropical cyc... ocean circulation patterns that transport heat a...e. According to Matthew Huber, Purdue University ...ciences who led the research group, the findings s...
...Over one hundred Long Island AARP members gathered...n before the end of the 2007 Legislative Session i...ore affordable and help assure that their cell pho...heir message directly to their legislators during ...
...aken up a rather strange hobby to help her keep fi...ly revealed that she has taken to the trapeze to k...for your confidence and amazing for your body but ... do something that pushed me,' the Daily Express q...
Other Medicine News:Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections 2
(Date:11/25/2008)...l Trial to Assess Survival of Patients Receiving L...able Hepatocellular Carcinoma , , BELLEVUE,...ology, Inc. (LSO) today announced the completion o... Light Infusion Therapy(TM) (Litx(TM)) as a treatm...), also known as hepatoma or primary liver cancer....
(Date:11/24/2008)...n, Nov. 24 Takeda Pharmaceutical C...keda Global Research & Development Center, Inc...ry Committee of the U.S. Food and Drug Administrat...tat for the treatment of hyperuricemia in patient...pproval, with one panel member abstaining. The vot...
(Date:11/24/2008)...swire-FirstCall/ -- Leaders of Schering-Plough Cor...or investors on the company,s research pipeline, h...ncludes 46 new entities in clinical trials or unde... , , "Research and development is adding st...ue our transformation," said Fred Hassan, chairman...
(Date:11/24/2008)... leadership and long-term commitment to hepatitis ...ewswire-FirstCall/ -- Schering-Plough Corporation ... boceprevir, its lead investigational oral hepatit...elopment. The company believes boceprevir has the...s protease inhibitor for treating chronic hepatiti...
Breaking Medicine Technology:Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 1ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 2ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 3Frito Lay Launches Low Sodium Versions of its Top Selling Snack Chips 16445 1Frito Lay Launches Low Sodium Versions of its Top Selling Snack Chips 16445 2Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 1Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 2Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 3Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 4Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 5Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 6Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 7Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 1Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 2Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 3Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 4
...il 20,2007-The U.S. Food and Drug,Administration (...sumers to the availability of audio broadcasts tha...oadcasts, commonly known as,podcasts, can be trans...ayers. , The service is part of the agency,s ongoi... concerning the safety of,marketed medications whe...
...at 160th Annual Meeting of the American,Psychiatri...re-FirstCall/ -- In adults with,major depressive d...rapy (ADT) resulted in significant improvement in ...ssion Rating Scale (MADRS),Total Score. In this si...nted here at the 160th Annual Meeting of the Ameri...
Other Medicine Technology:FDA Announces Audio Broadcasts on Emerging Drug Safety Information 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 3Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 5Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 6Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 7Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 8
The 96-Well GeneAmp PCR System 9700 can now be used with Gold-plated Silver and Aluminum Sample Blocks Modules. The aluminum block has been designed for routine use of PCR reactions and cycle sequenc
96 well thermocycler with unique High Temperature Range (HTR) Peltier technology for fastest available heating and cooling rates up to 4C/sec with High Pressure Lid for automated sealing of PCR plate
Ideal for day-to-day temperature cycling ,Unmatched well-to-well uniformity of 0.1C ,30% reduction in cycling time over Peltier or coolant-based cyclers ,4 programmable blocks eliminate tempera
...screen display which enables you to optimize your ...& Benefits include: Wide linear gradient, Touch S...alculator, Fold Control, High Performance, Versati...ment Software Upgrade. Includes a four year or 80...
Medicine Products: